Antipsychotic Drugs Linked to Increased Mortality Among Parkinson's Disease Patients
Penn, University of Michigan, and VA-led Study Analyzed Medical Records of 15,000 Parkinson's Patients
At least half of Parkinson's disease patients experience psychosis at some point during the course of their illness, and physicians commonly prescribe antipsychotic drugs, such as quetiapine, to treat the condition. However, a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania, the University of Michigan Medical School, and the Philadelphia and Ann Arbor Veterans Affairs (VA) Medical Centers and suggests that these drugs may do significantly more harm in a subset of patients.More Research
UDALL IN THE NEWS
06/04/16Muhammad Ali was still boxing professionally when observers first noticed signs of neurological decline, and many have been quick to link his profession…
06/04/16As the hushed sounds of a choir singing Chinese folk songs drifted in from an adjacent space, Yao Huang sat on a hard chair, lifting and stamping his feet…
FEATURED VIDEOVideo Archive
The 2016 Gail Gasser Lecture:
"The Genetic Architecture of Parkinson's Disease: Integrating data to provide novel insights"
Wednesday, October 12, 2016 | 12:00pm
Biomedical Research Building | Main Auditorium
Keynote speaker: Andrew Singleton, PhD, NIH Distinguished Investigator, Laboratory of Neurogenetics, National Institutes of Health (NIH)
Contact: Sadie Robinson at firstname.lastname@example.orgMore Events
© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.